SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-157864
Filing Date
2023-05-31
Accepted
2023-05-31 16:17:38
Documents
14
Period of Report
2023-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d507509d8k.htm   iXBRL 8-K 29609
2 EX-99.1 d507509dex991.htm EX-99.1 10732
6 GRAPHIC g507509g0527034335244.jpg GRAPHIC 3075
  Complete submission text file 0001193125-23-157864.txt   172702

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrx-20230531.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrx-20230531_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrx-20230531_pre.xml EX-101.PRE 11265
8 EXTRACTED XBRL INSTANCE DOCUMENT d507509d8k_htm.xml XML 3363
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 23981227
SIC: 2834 Pharmaceutical Preparations